Antimicrobial Drug Resistance

Clinical and Epidemiological Aspects

  • Douglas L. Mayers

Part of the Infectious Disease book series (ID)

Table of contents

  1. Front Matter
    Pages i-xxvi
  2. Gram-Positive Bacterial Drug Resistance – Clinical

    1. Lesley McGee, Keith P. Klugman
      Pages 681-693
    2. David J. Weber, William A. Rutala
      Pages 749-759
  3. Gram-Negative Bacterial Drug Resistance – Clinical

    1. Margaret C. Bash, Durrie L. McKnew, John W. Tapsall
      Pages 763-782
    2. David L. Paterson
      Pages 803-810
    3. David L. Paterson, Baek-Nam Kim
      Pages 811-817
    4. David L. Paterson, Anton Y. Peleg
      Pages 819-823
    5. Michael L. Bennish, Wasif A. Khan, Debasish Saha
      Pages 833-845
    6. Patrick F. McDermott, Joanne L. Simala-Grant, Diane E. Taylor
      Pages 847-863
    7. Michael A. Saubolle
      Pages 865-871
    8. Itzhak Brook
      Pages 873-899
    9. Francis A. Drobniewski, Yanina Balabanova
      Pages 901-915
    10. Kathleen Horan, Gerard A. Cangelosi
      Pages 917-927
  4. Fungal Drug Resistance – Clinical

    1. P. H. Chandrasekar, Elias K. Manavathu
      Pages 953-965
    2. Kimberly E. Hanson, Barbara D. Alexander, John Perfect
      Pages 967-985
    3. L. Joseph Wheat, Patricia Connolly, Melinda Smedema, P. David Rogers
      Pages 987-992
    4. Jannik Helweg-Larsen, Thomas Benfield, Joseph Kovacs, Henry Masur
      Pages 993-1007
  5. Viral Drug Resistance – Clinical

  6. Parasitic Drug Resistance – Clinical

    1. Philip J. Rosenthal
      Pages 1077-1090
    2. Shyam Sundar, Madhukar Rai
      Pages 1101-1112
    3. Jacques Pépin, Honoré Méda
      Pages 1113-1119
    4. Paul F. G. Sims
      Pages 1121-1126
  7. Measurements of Drug Resistance

    1. Robert W. Buckheit, R. Dwayne Lunsford
      Pages 1135-1149
    2. Leonid Heifets, Gerard Cangelosi
      Pages 1161-1170
    3. Sevtap Arikan, John H. Rex
      Pages 1171-1186
    4. Neil Parkin
      Pages 1187-1199
    5. N. C. Sangster, G. N. Maitland, S. Geerts, Saskia Decuypere, Jean-Claude Dujardin, J. A. Upcroft et al.
      Pages 1201-1225
    6. A. Huletsky, M. G. Bergeron
      Pages 1227-1248
  8. Public Health Issues of Drug Resistance

    1. Carlos A. DiazGranados, John E. Jr. McGowan
      Pages 1267-1276
    2. Linda M. Weigel, Stephen A. Morse
      Pages 1315-1338
    3. Matthew E. Falagas, Efthymia A. Karveli
      Pages 1339-1345
  9. Back Matter
    Pages 1347-1370

About this book


The volumes included in Antimicrobial Drug Resistance represent the first comprehensive, multidisciplinary reference covering the area of antimicrobial drug resistance in bacteria, fungi, viruses, and parasites from basic science, clinical, and epidemiological perspectives.

The first volume, Antimicrobial Drug Resistance, Mechanisms of Drug Resistance, is dedicated to the biological basis of drug resistance and effective avenues for drug development. With the emergence of more drug-resistant strains, the approach to dealing with the drug resistance problem must include the research of different aspects of the mechanisms of bacterial resistance and the dissemination of resistance genes as well as research utilizing new genomic information. These approaches will permit the design of novel strategies to develop new antibiotics and preserve the effectiveness of currently available ones.

The second volume, Antimicrobial Drug Resistance, Clinical and Epidemiological Aspects, is devoted to the clinical aspects of drug resistance. Although there is evidence that restricted use of a specific antibiotic can be followed by a decrease in drug resistance to that agent, drug resistance control is not easily achieved. Thus, the infectious disease physician requires input from the clinical microbiologist and infection control specialist to make informed choices for the effective treatment of various strains of drug-resistant pathogens in individual patients.

This 2-volume set is an important reference for students in microbiology, infectious disease physicians, medical students, basic scientists, drug development researchers, microbiologists, epidemiologists, and public health practitioners.


Antimicrobial Aspects Clinical Handbook Hepatitis International Public Health Malaria Mayers Resistance bacterial pathogens epidemiological infection infections infectious public health issues

Editors and affiliations

  • Douglas L. Mayers
    • 1
  1. 1.Executive Vice President & Chief Medical OfficerIdenix PharmaceuticalsCambridgeUSA

Bibliographic information